Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation

14 Nov 2019

Abstract excerpt

The oncogene ATPase family AAA domain‑containing protein 2 (ATAD2) has been demonstrated to promote malignancy in a number of different types of tumor; however, its expression and role in ovarian cancer (OC) remain unknown. In the present study, it was demonstrated that ATAD2 acts as both a marker and a driver of cell proliferation in OC. Immunohistochemistry (IHC) and bioinformatics analyses were used to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to CAR-T cell therapy research
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31746426
DOI: 10.3892/ijo.2019.4913

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferationPMID 31746426Read ↗

Evaluation of ATAD2 As a Potential Target in Hepatocellular CarcinomaSemantic proximity Read ↗

Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma.Semantic proximity Read ↗

Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.Semantic proximity Read ↗

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancersSemantic proximity Read ↗

Combining Bioinformatics and Experiments to Identify MAD2L2 as a Key Regulator in Ovarian CancerSemantic proximity Read ↗

MAD2L2, a key regulator in ovarian cancer and promoting tumor progressionSemantic proximity Read ↗

Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with OlaparibSemantic proximity Read ↗

ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinomaSemantic proximity Read ↗

A Novel Prognostic Biomarker ARRDC2 has Potential to Define Tumor Microenvironment in Ovarian CancerSemantic proximity Read ↗

ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic targetSemantic proximity Read ↗

Nuclear Receptor Coactivator 2 Promotes Human Breast Cancer Cell Growth by Positively Regulating the MAPK/ERK PathwaySemantic proximity Read ↗

UBE2T is upregulated, predicts poor prognosis, and promotes cell proliferation and invasion by promoting epithelial-mesenchymal transition via inhibiting autophagy in an AKT/mTOR dependent manner in ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.